|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03759 PHARMARON
Nominal 
17.300 -0.820 (-4.525%) | 2022/12 - Final RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 2,058,044 | 1,648,610 | 938,585 | 790,744 |
| Net Cash from / (used in) Investing Activities | -- | (5,258,147) | (3,371,051) | (1,045,203) | (714,599) |
| Net Cash from / (used in) Financing Activities | -- | 3,661,395 | (280,178) | 4,245,880 | (69,046) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 461,292 | (2,002,619) | 4,139,262 | 7,099 |
| Cash & Cash Equivalents at beginning of period | -- | 2,353,933 | 4,442,218 | 307,235 | 293,601 |
| Effect of Foreign Exchange Rate Changes | -- | (45,516) | (85,666) | (4,279) | 6,535 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 2,769,709 | 2,353,933 | 4,442,218 | 307,235 |
| Remarks: | Real time quote last updated: 04/10/2023 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 786,093 |
| %Change | 34.276% |
| EPS / (LPS) | RMB 0.444 |
| NBV Per Share (¥) | RMB 6.345 |